文献速递乳腺乳腺X线

乳腺微钙化:英国皇家学院5点乳腺影像系统与BI-RADS系统哪个能更好地预测恶性?

Breast microcalcifications: the UK RCR 5-point breast imaging system or BI-RADS; which is the better predictor of malignancy?
PubMed 文献 · Br J Radiol · 2019-08-09

该回顾性研究纳入241例乳腺X线摄影发现微钙化并接受活检的病例,比较英国皇家学院5点乳腺影像系统(UKS)与BI-RADS描述词对恶性的预测价值。结果显示,BI-RADS形态学与分布描述词组合可提高恶性预测准确性,并据此提出在UKS框架内使用BI-RADS描述词的算法。

要点

  • BI-RADS形态学描述词中,细线样/细线分支样微钙化的恶性阳性预测值最高(85.2%)。
  • BI-RADS分布描述词中,线样/段样分布的恶性阳性预测值最高(77.8%)。
  • 联合形态学与分布描述词可提高恶性预测准确性,并可在UKS框架内标准化报告。

核心结论

  • 联合微钙化的形态学与分布特征可准确预测恶性,使用BI-RADS描述词有助于在UKS内标准化报告,并提出了在UKS中使用这些描述词的算法。

研究设计与样本

  • 回顾性研究,纳入241例乳腺X线摄影发现微钙化并接受活检的病例,记录形态学、分布、范围、UKS评分、BI-RADS分类及病理结果,计算各分类系统的恶性阳性预测值。

关键影像表现/征象

  • 微钙化形态学按BI-RADS分类的恶性阳性预测值:无定形7.1%,粗糙不均质33.3%,细多形性48.1%,细线样/细线分支样85.2%(p < 0.001)。
  • 微钙化分布按BI-RADS分类的恶性阳性预测值:成组14.2%,区域32.3%,弥漫33.3%,线样/段样77.8%(p < 0.001)。
  • UKS评分M3、M4、M5的恶性阳性预测值分别为18.9%、69.4%、100%(p < 0.001)。

诊断标准与关键数值

  • BI-RADS形态学描述词:无定形、粗糙不均质、细多形性、细线样/细线分支样。
  • BI-RADS分布描述词:成组、区域、弥漫、线样/段样。
  • 联合良性表现、无定形、成组粗糙不均质及成组成组细多形性微钙化,恶性阳性预测值为12.8%。
  • 联合区域、线样或段样分布的粗糙不均质及细多形性微钙化,以及所有细线样/分支样微钙化,恶性阳性预测值为83.3%。

临床应用与阅片要点

  • 在UKS框架内报告微钙化时,可结合BI-RADS形态学与分布描述词进行恶性风险评估。
  • 联合形态学与分布特征有助于更准确预测恶性,从而进行更合适的咨询并识别差异。
  • 原文提出了一种供英国放射科医生评估微钙化时使用的算法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: In the UK RCR 5-point breast imaging system (UKS), radiologists grade mammograms from 1 to 5 according to suspicion for malignancy, however unlike BI-RADS, no lexicon of descriptors is published. The aim of this study was to determine whether strict categorisation of microcalcifications (MCC) according to BI-RADS was a better predictor of malignancy than the UKS and whether these descriptors could be used within the UKS.

METHODS: A retrospective review of 241 cases, with MCC on mammography, who underwent biopsy was performed. Morphology, distribution, extent, UKS score, BI-RADS category and pathology were recorded. The positive predictive value (PPV) of each classification system for malignancy was calculated.

RESULTS: 28.6% were diagnosed with DCIS/IDC. The PPV for malignancy using the UKS was 18.9%, 69.4%, 100% for M3-5 respectively (p < 0.001) and using ΒI-RADS morphology was amorphous: 7.1%, coarse heterogeneous: 33.3%, fine pleomorphic: 48.1% and fine linear/fine linear branching: 85.2% (p < 0.001). The PPV based on distribution was grouped: 14.2%, regional: 32.3%, diffuse: 33.3% and linear/segmental: 77.8% (p < 0.001). Combining all cases of benign-appearing, amorphous and grouped coarse heterogenous and grouped fine pleomorphic MCC gave a PPV of 12.8%. Combining regional, linear or segmental coarse heterogenous and fine pleomorphic and all fine linear/branching MCC resulted in a PPV of 83.3% for malignancy.

CONCLUSION: Combining morphology and distribution of MCC is accurate in malignancy prediction. Use of BI-RADS descriptors could help standardise reporting within the UKS and an algorithm using these within the UKS is proposed. Better prediction would enable more appropriate counselling and help to identify discrepancies.

ADVANCES IN KNOWLEDGE: No guidance exists on scoring of suspicious MCC in the UK breast imaging system. Use of BI-RADS morphologic/distribution descriptors can aid malignancy prediction. Findings other than morphology of MCC are important in malignancy prediction. An algorithm for use by the UK radiologist when evaluating MCC is provided.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Metaxa L, Healy NA, O'Keeffe SA, et al. Breast microcalcifications: the UK RCR 5-point breast imaging system or BI-RADS; which is the better predictor of malignancy? Br J Radiol. 2019. PMID: 31365279. doi:10.1259/bjr.20190177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。